Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 28,520 | 7,163 | 0 | 6,254 | 79,105 |
| Gross Profit | 28,520 | 7,163 | N/A | 6,254 | 79,105 |
| Operating Expenses | 73,940 | 71,809 | 94,114 | 138,942 | 143,881 |
| Operating Income | -45,420 | -64,646 | -94,114 | -132,688 | -64,776 |
| Other Income | 5,573 | 3,451 | 1,022 | 302 | 2,624 |
| Pre-tax Income | -39,847 | -61,195 | -93,092 | -132,386 | -62,152 |
| Income Tax | 330 | 33 | N/A | -2,531 | N/A |
| Net Income Continuous | -40,177 | -61,228 | -93,092 | -129,855 | -62,152 |
| Net Income | $-40,177 | $-61,228 | $-93,092 | $-129,855 | $-62,152 |
| EPS Basic Total Ops | -6.69 | -13.38 | -23.08 | -36.01 | -21.01 |
| EPS Basic Continuous Ops | -6.69 | -13.38 | -23.08 | -36.02 | -21.06 |
| EPS Diluted Total Ops | -6.69 | -13.38 | -23.08 | -36.01 | -21.01 |
| EPS Diluted Continuous Ops | -6.69 | -13.38 | -23.08 | -36.02 | -21.06 |
| EPS Diluted Before Non-Recurring Items | -6.69 | -13.38 | -23.05 | -24.49 | -21.01 |
| EBITDA(a) | $-48,949 | $-65,781 | $-93,461 | $-89,998 | $-64,098 |